1. Home
  2. BFC vs HROW Comparison

BFC vs HROW Comparison

Compare BFC & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank First Corporation

BFC

Bank First Corporation

HOLD

Current Price

$155.29

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

HROW

Harrow Inc.

HOLD

Current Price

$39.09

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFC
HROW
Founded
1894
1998
Country
United States
United States
Employees
N/A
373
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
BFC
HROW
Price
$155.29
$39.09
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$157.00
$69.86
AVG Volume (30 Days)
82.1K
548.8K
Earning Date
04-16-2026
05-11-2026
Dividend Yield
1.52%
N/A
EPS Growth
11.23
N/A
EPS
1.78
N/A
Revenue
N/A
N/A
Revenue This Year
$58.67
$31.62
Revenue Next Year
$2.01
$50.77
P/E Ratio
$85.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$115.29
$28.54
52 Week High
$154.42
$54.98

Technical Indicators

Market Signals
Indicator
BFC
HROW
Relative Strength Index (RSI) 64.11 42.50
Support Level $134.81 $37.81
Resistance Level N/A $41.82
Average True Range (ATR) 4.97 2.31
MACD 0.53 -0.69
Stochastic Oscillator 91.09 20.53

Price Performance

Historical Comparison
BFC
HROW

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services, a full range of consumer and commercial financial institution services to individuals and businesses, including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: